reactive cutaneous capillary endothelial proliferation(English)

• the most common adverse event related to camrelizumab, an immune checkpoint inhibitor
• ICI, IRAE, OS, PFS
• Endothelium, Microcirculation, Adverse effect
• https://doi.org…045-020-00886-2